Article

Clinical Centers of Excellence - Prostate Cancer: Mayo Clinic by the numbers

Clinical Centers of Excellence - Prostate Cancer: Mayo Clinic by the numbers

1989 – Prostate cancer center founded

27 – Treating urologists

1,200 – Radical prostatectomies performed in 2008

$4.3 million – Prostate cancer center's annual budget

4 – Open clinical trials

Related Videos
Vignesh Packiam, MD, on choosing between options in NMIBC
Vignesh Packiam, MD, on choosing between options in NMIBC
What’s Next for NMIBC: The Immunotherapy and Gene Therapy Pipeline
What’s Next for NMIBC: The Immunotherapy and Gene Therapy Pipeline
Weighing the Risks and Benefits of Bladder-Sparing Agents vs Cystectomy
Weighing the Risks and Benefits of Bladder-Sparing Agents vs Cystectomy
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Strategies to bridge gender disparities in AAS and citations in the oncology literature
Shot of a doctor showing a patient some information on a digital tablet | Image Credit | © bongkarn - stock.adobe.com
OnabotA for OAB: Enhancing comfort and ensuring adherence
Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC
Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC
Reflecting on NMIBC Progress: Highlights From AUA 2025 and What’s Ahead
Reflecting on NMIBC Progress: Highlights From AUA 2025 and What’s Ahead
Navigating Access Barriers: Resources to Support New Treatment Access
Navigating Access Barriers: Resources to Support New Treatment Access
Overcoming Challenges in Accessing New Therapies for NMIBC
Overcoming Challenges in Accessing New Therapies for NMIBC
Stacy Loeb, MD, MSc, PhD (Hon), answers a question during a Zoom video interview
Stacy Loeb, MD, MSc, PhD (Hon), discusses the nuances of prostate cancer screening
Related Content
Human Urinary System Kidneys with Bladder Anatomy | Image Credit: © magicmine - stock.adobe.com
June 13th 2025

CHAI biomarkers demonstrate prognostic utility for high-grade Ta NMIBC

Hannah Clarke
The CHAI biomarker was shown to outperform EAU and AUA stratifications.
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
June 2nd 2025

Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

Amy M. Pearlman, MD
3d rendered medically accurate illustration of prostate cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
June 13th 2025

64Cu-SAR-Bombesin shows efficacy in detecting prostate cancer recurrence

Hannah Clarke
The results from the SABRE trial are intended to support the design of a registrational trial of 64Cu-SAR-Bombesin.
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
May 17th 2025

Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

Amy M. Pearlman, MD Alex Tatem, MD
Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC
June 12th 2025

FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC

Hannah Clarke
The approval is supported by findings from the phase 3 ENVISION trial.
AI-based tool aims to optimize MRI use in prostate cancer diagnosis
June 12th 2025

AI-based tool aims to optimize MRI use in prostate cancer diagnosis

Madhur Nayan, MD, PhD
"I'm excited to see how these models are going to continue to be developed and applied in clinical practice, because precision medicine is here, and I’m looking forward to it," says Madhur Nayan, MD, PhD.
© 2025 MJH Life Sciences

All rights reserved.